Allergy Therapeutics' Worthing Facility Receives Certificate of GMP Compliance - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Allergy Therapeutics' Worthing Facility Receives Certificate of GMP Compliance


Allergy Therapeutics, a pharmaceutical company specialized in allergy vaccination, announced that its Worthing facility has received its Certificate of GMP Compliance following recent inspection by the MHRA.

During the past seven years, more than £10 million has been invested in the upgrade of this injectables facility. The facility has the capacity to further increase output and operating efficiencies, with more than 210,000 allergy vaccines and diagnostic tests manufactured at this site each year and over 95% of sales made overseas. In the past 12 months, products have been supplied to new markets including the Baltic States and New Zealand.

Allergy Therapeutics employs around 200 people in Worthing and is proud of it trading heritage, spanning nearly 80 years.

Source: Allergy Therapeutics

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes

Click here